IQVIA Holdings Inc. (NYSE:IQV) Stock Position Raised by Intact Investment Management Inc.

Intact Investment Management Inc. lifted its position in IQVIA Holdings Inc. (NYSE:IQV) by 21.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,180 shares of the medical research company’s stock after acquiring an additional 570 shares during the quarter. Intact Investment Management Inc.’s holdings in IQVIA were worth $754,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. Canada Pension Plan Investment Board lifted its position in shares of IQVIA by 6.6% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,403,488 shares of the medical research company’s stock valued at $719,634,000 after acquiring an additional 211,653 shares in the last quarter. Lazard Asset Management LLC lifted its position in IQVIA by 0.9% in the 1st quarter. Lazard Asset Management LLC now owns 3,263,944 shares of the medical research company’s stock worth $825,416,000 after buying an additional 30,014 shares in the last quarter. Farallon Capital Management LLC lifted its position in IQVIA by 3.1% in the 2nd quarter. Farallon Capital Management LLC now owns 2,923,032 shares of the medical research company’s stock worth $618,046,000 after buying an additional 86,870 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in IQVIA by 3.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,510,685 shares of the medical research company’s stock worth $634,927,000 after buying an additional 92,293 shares in the last quarter. Finally, Capital Research Global Investors lifted its position in IQVIA by 7.2% in the 1st quarter. Capital Research Global Investors now owns 2,138,802 shares of the medical research company’s stock worth $540,882,000 after buying an additional 143,533 shares in the last quarter. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Stock Performance

NYSE:IQV opened at $210.19 on Tuesday. IQVIA Holdings Inc. has a 1 year low of $190.20 and a 1 year high of $261.73. The firm’s fifty day simple moving average is $233.55 and its 200 day simple moving average is $229.64. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The firm has a market capitalization of $38.15 billion, a PE ratio of 27.58, a PEG ratio of 2.07 and a beta of 1.51.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on IQV. UBS Group increased their target price on shares of IQVIA from $295.00 to $300.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Jefferies Financial Group downgraded shares of IQVIA from a “buy” rating to a “hold” rating and cut their target price for the stock from $266.00 to $242.00 in a research report on Wednesday, July 24th. Redburn Atlantic assumed coverage on shares of IQVIA in a research report on Monday, October 14th. They issued a “buy” rating and a $276.00 target price for the company. TD Cowen cut their price target on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating on the stock in a report on Friday. Finally, BTIG Research cut their price target on shares of IQVIA from $290.00 to $260.00 and set a “buy” rating on the stock in a report on Friday. Four research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $261.56.

Insiders Place Their Bets

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the firm’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total value of $320,229.00. Following the sale, the insider now directly owns 19,536 shares in the company, valued at $4,812,302.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.60% of the company’s stock.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.